health - "medicine"

Cold and flu virus symptoms often mild in non-smokers can seriously hit smokers, according to a study by Yale School of medicine. The study identified the mechanism by which viruses and cigarette smo...

New Haven, Conn. - A new study by researchers at Yale School of medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers.

Cold and flu virus symptoms often mild in non-smokers can seriously hit smokers, according to a study by Yale School of medicine.

Perspective pieces in this week's New England Journal of medicine look at the health insurance coverage structure for biologic drugs and the Genetic Information Nondiscrimination Act. Summaries of the pieces appear below.

Elsevier and the Alzheimer's Association announced that Alzheimer's & Dementia: The Journal of the Alzheimer's Association (http://www.alzheimersanddementia.org/) has been selected for inclusion in MEDLINE. MEDLINE (http://www.pubmed.gov) is the premier bibliographic database of the National Library of medicine (NLM).

Age may not be rust after all. Specific genetic instructions drive aging in worms, report researchers at the Stanford University School of medicine. Their discovery contradicts the prevailing theory that aging is a buildup of tissue damage akin to rust, and implies science might eventually halt or even reverse the ravages of age. 'We were really surprised,' said Stuart Kim, PhD, professor of developmental biology and of genetics, who is the senior author of the research.

The New England Journal of medicine (NEJM) has today published the results of the Sorafenib HCC Assessment Randomized Protocol (SHARP) Phase 3 trial in which Nexavar® (sorafenib) tablets demonstrated that 'survival rates at 1 year were 44% in the sorafenib group and 33% in the placebo group.

Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.

A multi-institutional team led by Massachusetts General Hospital (MGH) investigators has developed a powerful new tool for genomic research and medicine - a robust method for generating synthetic enzymes that can target particular DNA sequences for inactivation or repair.

A multi-institutional team of researchers, including scientists at the University of Minnesota Medical School, have developed a powerful tool for genomic research and medicine. The robust method will allow researchers to generate synthetic enzymes that can target and manipulate DNA sequences for inactivation or repair. The potential for discovery is great, said Dan Voytas, Ph.D.